- Home
- AGEN vs SORA Comparison
AGEN vs SORA Comparison
Compare AGEN & SORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGEN | SORA |
|---|---|---|
| Founded | 1994 | 2001 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.2M | 131.0M |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | AGEN | SORA |
|---|---|---|
| Price | $3.12 | $3.00 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 639.2K | 9.5K |
| Earning Date | 11-10-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,829,000.00 | $14,081,504.00 |
| Revenue This Year | $67.15 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.38 | $1.80 |
| 52 Week High | $7.34 | $14.15 |
Technical Indicators
Market Signals| Indicator | AGEN | SORA |
|---|---|---|
| Relative Strength Index (RSI) | 26.40 | N/A |
| Support Level | $3.01 | N/A |
| Resistance Level | $4.00 | N/A |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 11.26 | 0.00 |
Price Performance
Historical ComparisonAbout AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About SORA Top Win International Limited Ordinary Shares
AsiaStrategy is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.